This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Anthony Metrano - Innovator in Cancer Treatment
Anthony Metrano is an inventor based in Gaithersburg, MD (US). He is known for his contributions to the field of cancer treatment through innovative chemical compounds. His work focuses on developing new therapeutic agents that can potentially improve patient outcomes in oncology.
Latest Patent Applications:
Anthony Metrano has filed a patent application titled "SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER." This application discloses certain substituted pyrazine-2-carboxamides of Formula (I), along with their pharmaceutically acceptable salts. The compounds are designed to inhibit hematopoietic progenitor kinase 1 (HPK1), making them particularly useful in the treatment or prophylaxis of cancer.
Conclusion:
Anthony Metrano's innovative approach to cancer treatment through his latest patent application highlights the potential of new chemical compounds in medical therapy. His work may pave the way for future advancements in oncology.